特爾佳(002213.SZ)收到出售特爾佳數據51%股權剩餘轉讓款100萬元
格隆匯12月17日丨特爾佳(002213.SZ)公佈,公司全資子公司深圳市特爾佳信息技術有限公司(以下簡稱“特爾佳信息”)將其持有的控股子公司深圳市特爾佳數據服務有限公司(以下簡稱“特爾佳數據”)全部股權(持股比例51.00%)以人民幣270萬元的交易價格出售給深圳市拓立彤博科技有限公司(以下簡稱“拓立彤博”)。2019年11月30日,公司披露了《關於出售控股子公司股權的進展公告》,特爾佳信息收到拓立彤博第一期轉讓對價款人民幣170萬元。
截至本公告日,特爾佳信息已收到剩餘的轉讓對價款人民幣100萬元。至此,特爾佳信息已收到上述股權轉讓事項的全部轉讓對價款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.